Contract for Remdesivir
A Voluntary Ex-Ante Transparency (VEAT) Notice
by NORTHERN HEALTH AND SOCIAL CARE TRUST
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- not specified
- Value
- £100K
- Sector
- HEALTH
- Published
- 30 Jan 2024
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Antrim
Geochart for 2 buyers and 1 suppliers
2 buyers
1 supplier
- Gilead Sciences London
Description
Contract for supply of Remdesivir Powder for infusion
Total Quantity or Scope
Contract for supply of Remdesivir Powder for infusion for maximum of 12 months
Award Detail
| 1 | Gilead Sciences (London)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Award on basis of price and quality.
Legal Justification
Regulation 32(2)(b)iii permits the award of a public contract by a negotiated procedure without prior publication where the works, supplies or services can only be supplied by a particular economic operator due to the protection of exclusive rights, including intellectual property rights. The absence of competition is not the result of an artificial narrowing down of the parameters of the procurement. The Northern Trust requires the purchase of Remdesivir injection which is subject to patent protection / Sole MA Holder and consequently no reasonable alternative of substitute exists.
Reference
- FTS 003118-2024